Skip to main content

Multiplex Immunofluorescence (mIF): Analytical Validation for Vectra 9C (MD Anderson)

BRD ID: 3109
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 1685

Description

This assay analytical validation and performance report describes the methods used to validate the multiplex immunofluorescence (mIF) assay for analysis with the Vectra 9C panel (CD34, CD3, CD45RO, FOXP3, PD1, PD-L1, and CD68) in paraffin sections of bone marrow clots from acute myeloid leukemia patients. The document also presents data supporting the reported accuracy, precision, analytical sensitivity, range, as well as quality control procedures. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at the MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).